CHRIS VERRICO to Cocaine-Related Disorders
This is a "connection" page, showing publications CHRIS VERRICO has written about Cocaine-Related Disorders.
Connection Strength
1.103
-
FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. Am J Addict. 2018 10; 27(7):567-573.
Score: 0.494
-
Rivastigmine does not alter cocaine-induced subjective effects or self-administration. Pharmacol Biochem Behav. 2019 10; 185:172758.
Score: 0.132
-
Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. Int J Neuropsychopharmacol. 2015 Sep 12; 19(3):pyv098.
Score: 0.101
-
Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Res. 2015 Nov 30; 230(1):44-9.
Score: 0.100
-
A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. J Psychopharmacol. 2015 Jan; 29(1):50-6.
Score: 0.095
-
The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014 Oct 30; 219(2):367-71.
Score: 0.092
-
Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:137-42.
Score: 0.089